Lyra Therapeutics Inc (NASDAQ: LYRA) is -58.87% lower on its value in year-to-date trading and has touched a low of $0.08 and a high of $5.77 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LYRA stock was last observed hovering at around $0.09 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.08, the stock is -38.19% and -50.40% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.27 million and changing -9.87% at the moment leaves the stock -63.10% off its SMA200. LYRA registered -98.38% loss for a year compared to 6-month loss of -61.16%. The firm has a 50-day simple moving average (SMA 50) of $0.1712 and a 200-day simple moving average (SMA200) of $0.230155.
The stock witnessed a -53.30% gain in the last 1 month and extending the period to 3 months gives it a -57.70%, and is -23.58% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.56% over the week and 12.65% over the month.
Lyra Therapeutics Inc (LYRA) has around 30 employees, a market worth around $5.60M and $1.53M in sales. Profit margin for the company is -6090.94%. Distance from 52-week low is 3.54% and -98.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-223.25%).
The EPS is expected to grow by 42.42% this year
76.0 institutions hold shares in Lyra Therapeutics Inc (LYRA), with institutional investors hold 51.28% of the company’s shares. The shares outstanding are 65.52M, and float is at 54.86M with Short Float at 4.40%. Institutions hold 50.85% of the Float.
The top institutional shareholder in the company is PERCEPTIVE ADVISORS LLC with over 12.76 million shares valued at $3.53 million. The investor’s holdings represent 19.4892 of the LYRA Shares outstanding. As of 2024-06-30, the second largest holder is CITADEL ADVISORS LLC with 4.77 million shares valued at $1.32 million to account for 7.2912 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 2.83 million shares representing 4.3232 and valued at over $0.78 million, while SAMSARA BIOCAPITAL, LLC holds 4.2473 of the shares totaling 2.78 million with a market value of $0.77 million.
